I.v. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat
- 1 January 2005
- journal article
- Published by Elsevier in Neuroscience
- Vol. 136 (1), 161-169
- https://doi.org/10.1016/j.neuroscience.2005.06.062
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NS43432)
- U.S. Department of Veterans Affairs
- National Multiple Sclerosis Society (CA1009A10, RG2135)
- Mitsui Sumitomo Insurance Welfare Foundation
- Ministry of Education, Culture, Sports, Science and Technology (14370442, 16390414)
This publication has 34 references indexed in Scilit:
- BDNF Gene-Modified Mesenchymal Stem Cells Promote Functional Recovery and Reduce Infarct Size in the Rat Middle Cerebral Artery Occlusion ModelMolecular Therapy, 2004
- Effective Gene Transfer to Human Melanomas via Integrin-Targeted Adenoviral VectorsHuman Gene Therapy, 2002
- Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem CellCell, 2001
- From Marrow to Brain: Expression of Neuronal Phenotypes in Adult MiceScience, 2000
- Intravenous Brain-Derived Neurotrophic Factor Reduces Infarct Size and Counterregulates Bax and Bcl-2 Expression After Temporary Focal Cerebral IschemiaStroke, 2000
- Serial MRI After Transient Focal Cerebral Ischemia in RatsStroke, 2000
- Adult rat and human bone marrow stromal cells differentiate into neuronsJournal of Neuroscience Research, 2000
- Persistent and Secondary Adenovirus-Mediated Hepatic Gene Expression Using Adenovirus Vector Containing CTLA4IgGHuman Gene Therapy, 1998
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke, 1986